Exela’s Management Is Brilliant: Debt Reduction And FCF Generation
Summary: Exela is a global business process automation company with operations in the United States, Europe, and other...
Year: 2021
Acadia: Big News On The Near Horizon
Summary: Acadia reported solid earnings for Q3, 2021 despite COVID-19 headwind lashing its Parkinson's Disease Psychosis ...
Aadi Bioscience: FDA Approval Of Fyarro Only The Beginning
Summary: Aadi Bioscience receives FDA approval of Fyarro for treatment of patients with PEComa.Fyarro (ABI-009) can be...
360 DigiTech Earns ‘Survivor’ Title After Latest Regulatory Wave
Summary: 360 DigiTech has reported strong third-quarter results, with both turnover and net income posting solid...
Exela Technologies: High Potential With Risks Including Catalysts For Upside
Summary: As seen by Exela's topline, not all digital transformation plays have been able to overcome Covid lows.Expenses...
Revisiting Zynerba Pharmaceuticals
Summary: Today, we revisit a small developmental firm called Zynerba Pharmaceuticals.The company is advancing its primary...
Affimed: Preparing For A Bullish 2022
Summary: Affimed reported mixed Q2 earnings that revealed more milestone payments from their partnerships. In addition,...
IPO Update: Cyngn Targets $30 Million IPO
Summary: Cyngn has filed proposed terms for a $30 million IPO.The firm is developing mobile robot automation software for...
360 DigiTech: Better Than Most Its Peers
Summary: I've compared 360 DigiTech's financials with its four most important peers.Based on the company’s growth,...
Cyngn Aims For $35 Million U.S. IPO
Summary: Cyngn has filed to raise $35 million in an IPO from the sale of its common stock.The firm is developing software...